Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
SOPHiA GENETICS
SOPH
$644M
| $51K | ﹤0.01% |
19,900
-1,700
| -8% | -$5.39K |
|
3402
Surf Air Mobility
SRFM
$97.8M
| $51K | ﹤0.01% |
+4,457
| New | +$53K |
|
3403
WidePoint Corp
WYY
$114M
| $51K | ﹤0.01% |
29,900
+4,000
| +15% | +$7.4K |
|
|
CHRN
3404
ChronoScale Holdings
CHRN
$3.02B
| $50K | ﹤0.01% |
4,581
+741
| +19% | +$11.5K |
|
|
FURY
3405
Fury Gold Mines
FURY
$116M
| $50K | ﹤0.01% |
145,102
+2,114
| +1% | +$792 |
|
|
GP
3406
GreenPower Motor Co
GP
$11.3M
| $49K | ﹤0.01% |
1,560
-1,240
| -44% | -$46.1K |
|
3407
Vista Gold
VGZ
$339M
| $49K | ﹤0.01% |
112,863
-320,737
| -74% | -$157K |
|
|
LVOX
3408
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $49K | ﹤0.01% |
14,700
-700
| -5% | -$2.15K |
|
|
BEDU
3409
DELISTED
Bright Scholar Education Holdings
BEDU
| $48K | ﹤0.01% |
42,025
-2,300
| -5% | -$2.52K |
|
|
KYNB
3410
Kyntra Bio
KYNB
$28.7M
| $48K | ﹤0.01% |
+2,240
| New | +$88K |
|
|
MOGU
3411
MOGU Inc
MOGU
$15.3M
| $48K | ﹤0.01% |
22,757
-4,300
| -16% | -$9.03K |
|
|
BMTX
3412
DELISTED
BM Technologies, Inc.
BMTX
| $48K | ﹤0.01% |
24,200
+5,700
| +31% | +$14K |
|
3413
Inuvo
INUV
$14.2M
| $47K | ﹤0.01% |
21,940
-2,870
| -12% | -$6.62K |
|
|
CASI
3414
DELISTED
CASI Pharmaceuticals
CASI
| $46K | ﹤0.01% |
17,800
+2,700
| +18% | +$6.39K |
|
|
ZSTK
3415
ZeroStack Corp
ZSTK
$21.1M
| $46K | ﹤0.01% |
1,023
+433
| +73% | +$39.3K |
|
3416
Lipocine
LPCN
$17M
| $46K | ﹤0.01% |
15,597
+5,200
| +50% | +$21.9K |
|
|
KA
3417
DELISTED
Kineta, Inc. Common Stock
KA
| $46K | ﹤0.01% |
13,544
-13,372
| -50% | -$29.6K |
|
|
SCPX
3418
DELISTED
Scorpius Holdings, Inc.
SCPX
| $46K | ﹤0.01% |
22
+4
| +22% | +$10.1K |
|
3419
Context Therapeutics
CNTX
$43.2M
| $45K | ﹤0.01% |
30,100
+1,800
| +6% | +$2.04K |
|
3420
Sky Harbour Group
SKYH
$396M
| $45K | ﹤0.01% |
+10,000
| New | +$44.5K |
|
3421
TScan Therapeutics
TCRX
$52.4M
| $45K | ﹤0.01% |
17,700
-129,762
| -88% | -$303K |
|
|
BEST
3422
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $45K | ﹤0.01% |
20,400
+500
| +3% | +$1.21K |
|
|
ENG
3423
DELISTED
ENGlobal Corp
ENG
| $45K | ﹤0.01% |
16,485
-14,528
| -47% | -$40.4K |
|
|
DHC
3424
Diversified Healthcare Trust
DHC
$2.02B
| $44K | ﹤0.01% |
+22,900
| New | +$58.1K |
|
3425
Xilio Therapeutics
XLO
$59.6M
| $44K | ﹤0.01% |
1,479
+29
| +2% | +$1.08K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.